世界のペプチド受容体放射性核種療法（PRRT）市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Peptide Receptor Radionuclide Therapy (PRRT) Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-5936 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、86ページ • 納品方法：Eメール（納期：3日） • 産業分類：医薬品

• 販売価格（消費税別）

Single User	￥577,200 (USD3,900)	▷ お問い合わせ
Multi User	￥865,800 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査レポートでは、ペプチド受容体放射性核種療法（PRRT）の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（胃腸膵臓神経内分泌腫瘍、前腸神経内分泌腫瘍、中腸神経内分泌腫瘍、後腸神経内分泌腫瘍）、用途別市場規模（病院薬局、小売薬局、オンライン薬局）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・ペプチド受容体放射性核種療法（PRRT）の市場動向 ・企業の競争状況、市場シェア ・ペプチド受容体放射性核種療法（PRRT）の種類別市場規模と予測2016-2027（胃腸膵臓神経内分泌腫瘍、前腸神経内分泌腫瘍、中腸神経内分泌腫瘍、後腸神経内分泌腫瘍） ・ペプチド受容体放射性核種療法（PRRT）の用途別市場規模と予測2016-2027（病院薬局、小売薬局、オンライン薬局） ・ペプチド受容体放射性核種療法（PRRT）の北米市場規模2016-2027（アメリカ、カナダ） ・ペプチド受容体放射性核種療法（PRRT）の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・ペプチド受容体放射性核種療法（PRRT）のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・ペプチド受容体放射性核種療法（PRRT）の中南米市場規模2016-2027（メキシコ、ブラジル） ・ペプチド受容体放射性核種療法（PRRT）の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Novartis、ITM Solucin、National Institutes of Health、Australasian Gastro-Intestinal Trials Group） ・結論

Peptide receptor radionuclide therapy (PRRT) is a type of molecular therapy, also known as radioisotope therapy that is used for treating neuroendocrine tumors. 

Market Analysis and Insights: Global Peptide Receptor Radionuclide Therapy (PRRT) Market
The global Peptide Receptor Radionuclide Therapy (PRRT) market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Peptide Receptor Radionuclide Therapy (PRRT) market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Peptide Receptor Radionuclide Therapy (PRRT) market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Peptide Receptor Radionuclide Therapy (PRRT) market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Peptide Receptor Radionuclide Therapy (PRRT) market.

Global Peptide Receptor Radionuclide Therapy (PRRT) Scope and Market Size
Peptide Receptor Radionuclide Therapy (PRRT) market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Peptide Receptor Radionuclide Therapy (PRRT) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Gastroenteropancreatic Neuroendocrine Tumor
Foregut Neuroendocrine Tumor
Midgut Neuroendocrine Tumor
Hindgut Neuroendocrine Tumor

Segment by Application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Novartis
ITM Solucin
National Institutes of Health
Australasian Gastro-Intestinal Trials Group

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Peptide Receptor Radionuclide Therapy (PRRT) Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Gastroenteropancreatic Neuroendocrine Tumor
1.2.3 Foregut Neuroendocrine Tumor
1.2.4 Midgut Neuroendocrine Tumor
1.2.5 Hindgut Neuroendocrine Tumor
1.3 Market by Application
1.3.1 Global Peptide Receptor Radionuclide Therapy (PRRT) Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Peptide Receptor Radionuclide Therapy (PRRT) Market Perspective (2016-2027)
2.2 Peptide Receptor Radionuclide Therapy (PRRT) Growth Trends by Regions
2.2.1 Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Peptide Receptor Radionuclide Therapy (PRRT) Historic Market Share by Regions (2016-2021)
2.2.3 Peptide Receptor Radionuclide Therapy (PRRT) Forecasted Market Size by Regions (2022-2027)
2.3 Peptide Receptor Radionuclide Therapy (PRRT) Industry Dynamic
2.3.1 Peptide Receptor Radionuclide Therapy (PRRT) Market Trends
2.3.2 Peptide Receptor Radionuclide Therapy (PRRT) Market Drivers
2.3.3 Peptide Receptor Radionuclide Therapy (PRRT) Market Challenges
2.3.4 Peptide Receptor Radionuclide Therapy (PRRT) Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Peptide Receptor Radionuclide Therapy (PRRT) Players by Revenue
3.1.1 Global Top Peptide Receptor Radionuclide Therapy (PRRT) Players by Revenue (2016-2021)
3.1.2 Global Peptide Receptor Radionuclide Therapy (PRRT) Revenue Market Share by Players (2016-2021)
3.2 Global Peptide Receptor Radionuclide Therapy (PRRT) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Peptide Receptor Radionuclide Therapy (PRRT) Revenue
3.4 Global Peptide Receptor Radionuclide Therapy (PRRT) Market Concentration Ratio
3.4.1 Global Peptide Receptor Radionuclide Therapy (PRRT) Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Peptide Receptor Radionuclide Therapy (PRRT) Revenue in 2020
3.5 Peptide Receptor Radionuclide Therapy (PRRT) Key Players Head office and Area Served
3.6 Key Players Peptide Receptor Radionuclide Therapy (PRRT) Product Solution and Service
3.7 Date of Enter into Peptide Receptor Radionuclide Therapy (PRRT) Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Peptide Receptor Radionuclide Therapy (PRRT) Breakdown Data by Type
4.1 Global Peptide Receptor Radionuclide Therapy (PRRT) Historic Market Size by Type (2016-2021)
4.2 Global Peptide Receptor Radionuclide Therapy (PRRT) Forecasted Market Size by Type (2022-2027)

5 Peptide Receptor Radionuclide Therapy (PRRT) Breakdown Data by Application
5.1 Global Peptide Receptor Radionuclide Therapy (PRRT) Historic Market Size by Application (2016-2021)
5.2 Global Peptide Receptor Radionuclide Therapy (PRRT) Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Peptide Receptor Radionuclide Therapy (PRRT) Market Size (2016-2027)
6.2 North America Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Type
6.2.1 North America Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Type (2016-2021)
6.2.2 North America Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Type (2022-2027)
6.2.3 North America Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Type (2016-2027)
6.3 North America Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Application
6.3.1 North America Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Application (2016-2021)
6.3.2 North America Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Application (2022-2027)
6.3.3 North America Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Application (2016-2027)
6.4 North America Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Country
6.4.1 North America Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Country (2016-2021)
6.4.2 North America Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Peptide Receptor Radionuclide Therapy (PRRT) Market Size (2016-2027)
7.2 Europe Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Type
7.2.1 Europe Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Type (2016-2021)
7.2.2 Europe Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Type (2022-2027)
7.2.3 Europe Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Type (2016-2027)
7.3 Europe Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Application
7.3.1 Europe Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Application (2016-2021)
7.3.2 Europe Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Application (2022-2027)
7.3.3 Europe Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Application (2016-2027)
7.4 Europe Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Country
7.4.1 Europe Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Country (2016-2021)
7.4.2 Europe Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Peptide Receptor Radionuclide Therapy (PRRT) Market Size (2016-2027)
8.2 Asia-Pacific Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Type
8.2.1 Asia-Pacific Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Type (2016-2027)
8.3 Asia-Pacific Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Application
8.3.1 Asia-Pacific Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Application (2016-2027)
8.4 Asia-Pacific Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Region
8.4.1 Asia-Pacific Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Peptide Receptor Radionuclide Therapy (PRRT) Market Size (2016-2027)
9.2 Latin America Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Type
9.2.1 Latin America Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Type (2016-2021)
9.2.2 Latin America Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Type (2022-2027)
9.2.3 Latin America Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Type (2016-2027)
9.3 Latin America Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Application
9.3.1 Latin America Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Application (2016-2021)
9.3.2 Latin America Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Application (2022-2027)
9.3.3 Latin America Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Application (2016-2027)
9.4 Latin America Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Country
9.4.1 Latin America Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Country (2016-2021)
9.4.2 Latin America Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Peptide Receptor Radionuclide Therapy (PRRT) Market Size (2016-2027)
10.2 Middle East & Africa Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Type
10.2.1 Middle East & Africa Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Type (2016-2027)
10.3 Middle East & Africa Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Application
10.3.1 Middle East & Africa Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Application (2016-2027)
10.4 Middle East & Africa Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Country
10.4.1 Middle East & Africa Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Novartis
11.1.1 Novartis Company Details
11.1.2 Novartis Business Overview
11.1.3 Novartis Peptide Receptor Radionuclide Therapy (PRRT) Introduction
11.1.4 Novartis Revenue in Peptide Receptor Radionuclide Therapy (PRRT) Business (2016-2021)
11.1.5 Novartis Recent Development
11.2 ITM Solucin
11.2.1 ITM Solucin Company Details
11.2.2 ITM Solucin Business Overview
11.2.3 ITM Solucin Peptide Receptor Radionuclide Therapy (PRRT) Introduction
11.2.4 ITM Solucin Revenue in Peptide Receptor Radionuclide Therapy (PRRT) Business (2016-2021)
11.2.5 ITM Solucin Recent Development
11.3 National Institutes of Health
11.3.1 National Institutes of Health Company Details
11.3.2 National Institutes of Health Business Overview
11.3.3 National Institutes of Health Peptide Receptor Radionuclide Therapy (PRRT) Introduction
11.3.4 National Institutes of Health Revenue in Peptide Receptor Radionuclide Therapy (PRRT) Business (2016-2021)
11.3.5 National Institutes of Health Recent Development
11.4 Australasian Gastro-Intestinal Trials Group
11.4.1 Australasian Gastro-Intestinal Trials Group Company Details
11.4.2 Australasian Gastro-Intestinal Trials Group Business Overview
11.4.3 Australasian Gastro-Intestinal Trials Group Peptide Receptor Radionuclide Therapy (PRRT) Introduction
11.4.4 Australasian Gastro-Intestinal Trials Group Revenue in Peptide Receptor Radionuclide Therapy (PRRT) Business (2016-2021)
11.4.5 Australasian Gastro-Intestinal Trials Group Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Peptide Receptor Radionuclide Therapy (PRRT) Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Gastroenteropancreatic Neuroendocrine Tumor
Table 3. Key Players of Foregut Neuroendocrine Tumor
Table 4. Key Players of Midgut Neuroendocrine Tumor
Table 5. Key Players of Hindgut Neuroendocrine Tumor
Table 6. Global Peptide Receptor Radionuclide Therapy (PRRT) Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global Peptide Receptor Radionuclide Therapy (PRRT) Market Share by Regions (2016-2021)
Table 10. Global Peptide Receptor Radionuclide Therapy (PRRT) Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global Peptide Receptor Radionuclide Therapy (PRRT) Market Share by Regions (2022-2027)
Table 12. Peptide Receptor Radionuclide Therapy (PRRT) Market Trends
Table 13. Peptide Receptor Radionuclide Therapy (PRRT) Market Drivers
Table 14. Peptide Receptor Radionuclide Therapy (PRRT) Market Challenges
Table 15. Peptide Receptor Radionuclide Therapy (PRRT) Market Restraints
Table 16. Global Peptide Receptor Radionuclide Therapy (PRRT) Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global Peptide Receptor Radionuclide Therapy (PRRT) Market Share by Players (2016-2021)
Table 18. Global Top Peptide Receptor Radionuclide Therapy (PRRT) Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Peptide Receptor Radionuclide Therapy (PRRT) as of 2020)
Table 19. Ranking of Global Top Peptide Receptor Radionuclide Therapy (PRRT) Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by Peptide Receptor Radionuclide Therapy (PRRT) Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Peptide Receptor Radionuclide Therapy (PRRT) Product Solution and Service
Table 23. Date of Enter into Peptide Receptor Radionuclide Therapy (PRRT) Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Type (2016-2021) (US$ Million)
Table 26. Global Peptide Receptor Radionuclide Therapy (PRRT) Revenue Market Share by Type (2016-2021)
Table 27. Global Peptide Receptor Radionuclide Therapy (PRRT) Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global Peptide Receptor Radionuclide Therapy (PRRT) Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 29. Global Peptide Receptor Radionuclide Therapy (PRRT) Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global Peptide Receptor Radionuclide Therapy (PRRT) Revenue Market Share by Application (2016-2021)
Table 31. Global Peptide Receptor Radionuclide Therapy (PRRT) Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global Peptide Receptor Radionuclide Therapy (PRRT) Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Type (2016-2021) (US$ Million)
Table 34. North America Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Type (2022-2027) & (US$ Million)
Table 35. North America Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Application (2016-2021) (US$ Million)
Table 36. North America Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Type (2016-2021) (US$ Million)
Table 40. Europe Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Type (2022-2027) & (US$ Million)
Table 41. Europe Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Type (2016-2021) (US$ Million)
Table 46. Asia-Pacific Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Type (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Type (2016-2021) (US$ Million)
Table 52. Latin America Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Type (2022-2027) & (US$ Million)
Table 53. Latin America Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Type (2016-2021) (US$ Million)
Table 58. Middle East & Africa Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Type (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Country (2022-2027) & (US$ Million)
Table 63. Novartis Company Details
Table 64. Novartis Business Overview
Table 65. Novartis Peptide Receptor Radionuclide Therapy (PRRT) Product
Table 66. Novartis Revenue in Peptide Receptor Radionuclide Therapy (PRRT) Business (2016-2021) & (US$ Million)
Table 67. Novartis Recent Development
Table 68. ITM Solucin Company Details
Table 69. ITM Solucin Business Overview
Table 70. ITM Solucin Peptide Receptor Radionuclide Therapy (PRRT) Product
Table 71. ITM Solucin Revenue in Peptide Receptor Radionuclide Therapy (PRRT) Business (2016-2021) & (US$ Million)
Table 72. ITM Solucin Recent Development
Table 73. National Institutes of Health Company Details
Table 74. National Institutes of Health Business Overview
Table 75. National Institutes of Health Peptide Receptor Radionuclide Therapy (PRRT) Product
Table 76. National Institutes of Health Revenue in Peptide Receptor Radionuclide Therapy (PRRT) Business (2016-2021) & (US$ Million)
Table 77. National Institutes of Health Recent Development
Table 78. Australasian Gastro-Intestinal Trials Group Company Details
Table 79. Australasian Gastro-Intestinal Trials Group Business Overview
Table 80. Australasian Gastro-Intestinal Trials Group Peptide Receptor Radionuclide Therapy (PRRT) Product
Table 81. Australasian Gastro-Intestinal Trials Group Revenue in Peptide Receptor Radionuclide Therapy (PRRT) Business (2016-2021) & (US$ Million)
Table 82. Australasian Gastro-Intestinal Trials Group Recent Development
Table 83. Research Programs/Design for This Report
Table 84. Key Data Information from Secondary Sources
Table 85. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Peptide Receptor Radionuclide Therapy (PRRT) Market Share by Type: 2020 VS 2027
Figure 2. Gastroenteropancreatic Neuroendocrine Tumor Features
Figure 3. Foregut Neuroendocrine Tumor Features
Figure 4. Midgut Neuroendocrine Tumor Features
Figure 5. Hindgut Neuroendocrine Tumor Features
Figure 6. Global Peptide Receptor Radionuclide Therapy (PRRT) Market Share by Application: 2020 VS 2027
Figure 7. Hospital Pharmacies Case Studies
Figure 8. Retail Pharmacies Case Studies
Figure 9. Online Pharmacies Case Studies
Figure 10. Peptide Receptor Radionuclide Therapy (PRRT) Report Years Considered
Figure 11. Global Peptide Receptor Radionuclide Therapy (PRRT) Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global Peptide Receptor Radionuclide Therapy (PRRT) Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Peptide Receptor Radionuclide Therapy (PRRT) Market Share by Regions: 2020 VS 2027
Figure 14. Global Peptide Receptor Radionuclide Therapy (PRRT) Market Share by Regions (2022-2027)
Figure 15. Global Peptide Receptor Radionuclide Therapy (PRRT) Market Share by Players in 2020
Figure 16. Global Top Peptide Receptor Radionuclide Therapy (PRRT) Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Peptide Receptor Radionuclide Therapy (PRRT) as of 2020
Figure 17. The Top 10 and 5 Players Market Share by Peptide Receptor Radionuclide Therapy (PRRT) Revenue in 2020
Figure 18. Global Peptide Receptor Radionuclide Therapy (PRRT) Revenue Market Share by Type (2016-2021)
Figure 19. Global Peptide Receptor Radionuclide Therapy (PRRT) Revenue Market Share by Type (2022-2027)
Figure 20. North America Peptide Receptor Radionuclide Therapy (PRRT) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America Peptide Receptor Radionuclide Therapy (PRRT) Market Share by Type (2016-2027)
Figure 22. North America Peptide Receptor Radionuclide Therapy (PRRT) Market Share by Application (2016-2027)
Figure 23. North America Peptide Receptor Radionuclide Therapy (PRRT) Market Share by Country (2016-2027)
Figure 24. United States Peptide Receptor Radionuclide Therapy (PRRT) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada Peptide Receptor Radionuclide Therapy (PRRT) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Peptide Receptor Radionuclide Therapy (PRRT) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Peptide Receptor Radionuclide Therapy (PRRT) Market Share by Type (2016-2027)
Figure 28. Europe Peptide Receptor Radionuclide Therapy (PRRT) Market Share by Application (2016-2027)
Figure 29. Europe Peptide Receptor Radionuclide Therapy (PRRT) Market Share by Country (2016-2027)
Figure 30. Germany Peptide Receptor Radionuclide Therapy (PRRT) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France Peptide Receptor Radionuclide Therapy (PRRT) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. Peptide Receptor Radionuclide Therapy (PRRT) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy Peptide Receptor Radionuclide Therapy (PRRT) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia Peptide Receptor Radionuclide Therapy (PRRT) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic Peptide Receptor Radionuclide Therapy (PRRT) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Peptide Receptor Radionuclide Therapy (PRRT) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Peptide Receptor Radionuclide Therapy (PRRT) Market Share by Type (2016-2027)
Figure 38. Asia-Pacific Peptide Receptor Radionuclide Therapy (PRRT) Market Share by Application (2016-2027)
Figure 39. Asia-Pacific Peptide Receptor Radionuclide Therapy (PRRT) Market Share by Region (2016-2027)
Figure 40. China Peptide Receptor Radionuclide Therapy (PRRT) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan Peptide Receptor Radionuclide Therapy (PRRT) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea Peptide Receptor Radionuclide Therapy (PRRT) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia Peptide Receptor Radionuclide Therapy (PRRT) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India Peptide Receptor Radionuclide Therapy (PRRT) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia Peptide Receptor Radionuclide Therapy (PRRT) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Peptide Receptor Radionuclide Therapy (PRRT) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Peptide Receptor Radionuclide Therapy (PRRT) Market Share by Type (2016-2027)
Figure 48. Latin America Peptide Receptor Radionuclide Therapy (PRRT) Market Share by Application (2016-2027)
Figure 49. Latin America Peptide Receptor Radionuclide Therapy (PRRT) Market Share by Country (2016-2027)
Figure 50. Mexico Peptide Receptor Radionuclide Therapy (PRRT) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil Peptide Receptor Radionuclide Therapy (PRRT) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Peptide Receptor Radionuclide Therapy (PRRT) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Peptide Receptor Radionuclide Therapy (PRRT) Market Share by Type (2016-2027)
Figure 54. Middle East & Africa Peptide Receptor Radionuclide Therapy (PRRT) Market Share by Application (2016-2027)
Figure 55. Middle East & Africa Peptide Receptor Radionuclide Therapy (PRRT) Market Share by Country (2016-2027)
Figure 56. Turkey Peptide Receptor Radionuclide Therapy (PRRT) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia Peptide Receptor Radionuclide Therapy (PRRT) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE Peptide Receptor Radionuclide Therapy (PRRT) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Novartis Revenue Growth Rate in Peptide Receptor Radionuclide Therapy (PRRT) Business (2016-2021)
Figure 60. ITM Solucin Revenue Growth Rate in Peptide Receptor Radionuclide Therapy (PRRT) Business (2016-2021)
Figure 61. National Institutes of Health Revenue Growth Rate in Peptide Receptor Radionuclide Therapy (PRRT) Business (2016-2021)
Figure 62. Australasian Gastro-Intestinal Trials Group Revenue Growth Rate in Peptide Receptor Radionuclide Therapy (PRRT) Business (2016-2021)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed

---